Literature DB >> 23860347

Single-dose oral lacosamide in refractory simple partial status epilepticus: case report and review.

Maximiliano A Hawkes1, Marcos Fernández Suárez, Gabriela Ugarnes, Carlos D'Giano.   

Abstract

OBJECTIVES: This study aimed to present 2 patients with simple partial refractory status epilepticus (RSE) treated with a single oral lacosamide (LCM) dose and to review the literature on this topic.
METHOD: A retrospective description of 2 patients with simple partial RSE treated with 300 mg of LCM per os (p.o.) and a literature review were done.
RESULTS: Both patients responded to single-dose oral LCM treatment with seizure cessation after 30 minutes.
CONCLUSIONS: This is the first report on successful treatment of simple partial RSE with a single-dose of LCM p.o.. Oral LCM might represent an option for treatment of patients presenting with simple partial RSE.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23860347     DOI: 10.1097/WNF.0b013e31829b21ba

Source DB:  PubMed          Journal:  Clin Neuropharmacol        ISSN: 0362-5664            Impact factor:   1.592


  2 in total

Review 1.  The efficacy of lacosamide as monotherapy and adjunctive therapy in focal epilepsy and its use in status epilepticus: clinical trial evidence and experience.

Authors:  Sebastian Bauer; Laurent M Willems; Esther Paule; Christine Petschow; Johann Philipp Zöllner; Felix Rosenow; Adam Strzelczyk
Journal:  Ther Adv Neurol Disord       Date:  2016-11-29       Impact factor: 6.570

2.  Safety of intravenous lacosamide in critically ill children.

Authors:  Sarah S Welsh; Nan Lin; Alexis A Topjian; Nicholas S Abend
Journal:  Seizure       Date:  2017-10-03       Impact factor: 3.184

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.